nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.813	1	CbGbCtD
Triamterene—SCNN1G—Stimuli-sensing channels—TRPM7—amyotrophic lateral sclerosis	0.0146	0.0988	CbGpPWpGaD
Triamterene—SCNN1D—Stimuli-sensing channels—TRPM7—amyotrophic lateral sclerosis	0.0146	0.0988	CbGpPWpGaD
Triamterene—SCNN1B—Stimuli-sensing channels—TRPM7—amyotrophic lateral sclerosis	0.0146	0.0988	CbGpPWpGaD
Triamterene—SCNN1A—Stimuli-sensing channels—TRPM7—amyotrophic lateral sclerosis	0.0146	0.0988	CbGpPWpGaD
Triamterene—SCNN1D—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00951	0.0645	CbGpPWpGaD
Triamterene—SCNN1A—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00951	0.0645	CbGpPWpGaD
Triamterene—SCNN1G—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00951	0.0645	CbGpPWpGaD
Triamterene—SCNN1B—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.00951	0.0645	CbGpPWpGaD
Triamterene—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00654	0.172	CcSEcCtD
Triamterene—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00533	0.14	CcSEcCtD
Triamterene—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00354	0.0933	CcSEcCtD
Triamterene—SCNN1A—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00331	0.0224	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00331	0.0224	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00331	0.0224	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00331	0.0224	CbGpPWpGaD
Triamterene—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00283	0.0745	CcSEcCtD
Triamterene—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00245	0.0646	CcSEcCtD
Triamterene—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00234	0.0615	CcSEcCtD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00213	0.0145	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00213	0.0145	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00213	0.0145	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00213	0.0145	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.00199	0.0135	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00181	0.0123	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00181	0.0123	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00181	0.0123	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00181	0.0123	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00181	0.0123	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00181	0.0123	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00181	0.0123	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00181	0.0123	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00162	0.011	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00162	0.011	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00162	0.011	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00162	0.011	CbGpPWpGaD
Triamterene—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00156	0.0411	CcSEcCtD
Triamterene—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00153	0.0402	CcSEcCtD
Triamterene—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.0015	0.0394	CcSEcCtD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00143	0.0097	CbGpPWpGaD
Triamterene—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00132	0.0347	CcSEcCtD
Triamterene—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00113	0.0297	CcSEcCtD
Triamterene—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.0011	0.0289	CcSEcCtD
Triamterene—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00105	0.0275	CcSEcCtD
Triamterene—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00101	0.0266	CcSEcCtD
Triamterene—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000972	0.0256	CcSEcCtD
Triamterene—Rash—Riluzole—amyotrophic lateral sclerosis	0.000964	0.0254	CcSEcCtD
Triamterene—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000963	0.0254	CcSEcCtD
Triamterene—Headache—Riluzole—amyotrophic lateral sclerosis	0.000958	0.0252	CcSEcCtD
Triamterene—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000908	0.0239	CcSEcCtD
Triamterene—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000522	0.00354	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00041	0.00278	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000371	0.00252	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000286	0.00194	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000284	0.00193	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000261	0.00177	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000247	0.00168	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000243	0.00165	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000231	0.00157	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000228	0.00155	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000195	0.00132	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000166	0.00113	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000164	0.00111	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000157	0.00106	CbGpPWpGaD
Triamterene—SCNN1D—nervous system—amyotrophic lateral sclerosis	0.000139	0.133	CbGeAlD
Triamterene—SCNN1D—central nervous system—amyotrophic lateral sclerosis	0.000134	0.128	CbGeAlD
Triamterene—SCNN1D—cerebellum—amyotrophic lateral sclerosis	0.000131	0.125	CbGeAlD
Triamterene—SCNN1G—cerebellum—amyotrophic lateral sclerosis	0.000131	0.125	CbGeAlD
Triamterene—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000127	0.000863	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000127	0.000863	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000119	0.000805	CbGpPWpGaD
Triamterene—SCNN1B—nervous system—amyotrophic lateral sclerosis	0.000118	0.112	CbGeAlD
Triamterene—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000116	0.00079	CbGpPWpGaD
Triamterene—SCNN1B—central nervous system—amyotrophic lateral sclerosis	0.000113	0.108	CbGeAlD
Triamterene—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000108	0.000734	CbGpPWpGaD
Triamterene—SCNN1D—brain—amyotrophic lateral sclerosis	0.000107	0.102	CbGeAlD
Triamterene—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000102	0.00069	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	9.2e-05	0.000624	CbGpPWpGaD
Triamterene—SCNN1B—brain—amyotrophic lateral sclerosis	9e-05	0.086	CbGeAlD
Triamterene—SCNN1A—brain—amyotrophic lateral sclerosis	8.32e-05	0.0794	CbGeAlD
Triamterene—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	6.97e-05	0.000473	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	6.44e-05	0.000437	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.86e-05	0.000398	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	5.29e-05	0.000358	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.82e-05	0.000327	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.3e-05	0.000224	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.84e-05	0.000193	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.61e-05	0.000177	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	2.15e-05	0.000146	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.47e-05	9.98e-05	CbGpPWpGaD
